Bil­lion­aire-backed Ju­ve­nes­cence primes the an­ti-ag­ing pipeline pump with a $12M seed round

Ju­ve­nes­cence CEO Greg Bai­ley told me back in Ju­ly that he ex­pect­ed he would have to raise hun­dreds of mil­lions of dol­lars to push the pipeline of an­ti-ag­ing reme­dies he planned to cre­ate. But he’s start­ing on a much more mod­est lev­el.

The biotech, backed by some well rec­og­nized names in­clud­ing UK bil­lion­aire Jim Mel­lon, an­nounced that they have put to­geth­er their first seed round of $12.3 mil­lion.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.